“Half-Life-Extended Monoclonal Antibody APG777 for Atopic Dermatitis: Design of the Phase 2 APEX Study”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s456. https://doi.org/10.25251/skin.8.supp.456.